DNA Halted. Here’s The Story, And The Other Stocks Involved

Stocks are lower Monday after
WalMart gave a weaker-than-expected Black Friday sales report.

Wal Mart
(
WMT |
Quote |
Chart |
News |
PowerRating)
cut its November sales forecast, saying sales in the
week ended Black Friday did not meet expectations.

Genentech
(
DNA |
Quote |
Chart |
News |
PowerRating)
was halted earlier in
the day. Its Avastin was shown to extend survival in colorectal cancer. The
stock gapped up upon re-opening and is trading at 50, up 1.14. Protein Design
Labs

(
PDLI |
Quote |
Chart |
News |
PowerRating)
, which receives royalties on Avastin from Genetech, rose.
Imclone
(
IMCL |
Quote |
Chart |
News |
PowerRating)
fell on the news.

Microsoft
(
MSFT |
Quote |
Chart |
News |
PowerRating)
will distribute its
special $3/share dividend on Thursday; $33 billion will be distributed–$10
billion to individuals and $22..6 to institutions.

Making new highs today include: the Russell 2000,
Mid-Cap Index, Transports and Utilities.

Dow -88.08 10434.15
S&P 500 -8.13 1174.52
Nasdaq -7.08 2094.89

Strong sectors are: Gold
(
XAU.X |
Quote |
Chart |
News |
PowerRating)

+0.77%, Telecom
(
XTC.X |
Quote |
Chart |
News |
PowerRating)
+0.26%.

Weak are: Oil Services
(
OSX.X |
Quote |
Chart |
News |
PowerRating)

-1.86%, Natural Gas
(
XNG.X |
Quote |
Chart |
News |
PowerRating)
-1.75%, Retail
(
RLX.X |
Quote |
Chart |
News |
PowerRating)

-1.32%.

The dollar is +0.08 at 81.96

Gold is +4.10 to 454.30

Crude Oil is +0.16 at 49.60

ce=”Arial” size=”2″ face=”Arial”>Volume is 702 million on the NYSE and 1
billion on the Nasdaq.

Market breadth is negative.

NYSE Issues
Advancing 1088 Up Vol 205
Declining 2167 Down Vol 438
Ratio 1.99 2.13
Nasdaq
Advancing 1329 Up Vol 369
Declining 1658 Down Vol 600
Ratio 1.24 1.69

Stocks in the News.

Nike
(
NKE |
Quote |
Chart |
News |
PowerRating)
was the subject of a positive article in Barron’s.

Apple Computer’s
(
AAPL |
Quote |
Chart |
News |
PowerRating)
price target was raised at Merrill Lynch,
to $78.

Forest Labs’
(
FRX |
Quote |
Chart |
News |
PowerRating)
pain medication Combunox was approved by the
FDA.

Electronic Data Systems
(
EDS |
Quote |
Chart |
News |
PowerRating)
received at 10-year, $382 million
contract from the government of British Columbia.

Gateway
(
GTW |
Quote |
Chart |
News |
PowerRating)
was the subject of a positive article in Barron’s
which gave a $7 price target.

Brice Wightman